Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL725624 | 0.95 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL10584206 | 0.95 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL2578971 | 0.93 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL11542880 | 0.91 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL3683178 | 0.88 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL3957478 | 0.88 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL10338272 | 0.86 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL309351 | 0.86 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL17425057 | 0.85 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 | |
| SCHEMBL30638280 | 0.84 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2MAPK1HIF1ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113166570-B | Aqueous dispersion of resin particles | 爱克发-格法特公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-115954149-A | Torsion-resistant robot arm cable and preparation method thereof | 上海古乾智能传输有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-111199812-B | Robot arm is with twisting reverse flexible cable | 安徽联嘉祥特种电缆有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-113227194-A | Photosensitive resin composition | 日本化药株式会社 | 2021-08-06 | — | — | CN | disclosed |
| CN-111199812-A | Robot arm is with twisting reverse flexible cable | 深圳市联嘉祥科技股份有限公司 | 2020-05-26 | — | — | CN | disclosed |
| WO-2020054502-A1 | ACTINIC RAY CURABLE COMPOSITION AND FILM USING SAME | DIC株式会社 | 2020-03-19 | — | — | WO | disclosed |
| US-9567284-B2 | Hexaester of mono-formal bis pentaerythritol | KH NEOCHEM CO., LTD. (JP) | 2017-02-14 | — | — | US | disclosed |
| US-20160311751-A1 | HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL | KH NEOCHEM CO., LTD. (JP) | 2016-10-27 | — | — | US | disclosed |
| US-9365484-B2 | Hexaester of mono-formal bis pentaerythritol | KH NEOCHEM CO., LTD. (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20150291502-A1 | HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL | KH NEOCHEM CO., LTD. (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-0765862-B1 | FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL | KAO CORP (JP) | 2000-03-08 | — | — | EP | disclosed |
| EP-0765862-A1 | FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL | Kao Corporation (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0363171-B1 | Method of and apparatus for forming volume type phase hologram | FUJITSU LTD (JP) | 1994-02-23 | — | — | EP | disclosed |
| EP-0363171-A2 | Method of and apparatus for forming volume type phase hologram | FUJITSU LIMITED (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4496535-A | SHAPE-MEMORY, DIMENSIONAL STABILITY | TYNDALE PLAINS-HUNTER, LTD. (US) | 1985-01-29 | — | — | US | disclosed |
| US-4490423-A | POLYURETHANE MODIFIED WITH UNSATURATED ESTER | TYNDALE PLAINS-HUNTER, LTD. (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0123679-A1 | ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF | SRI INTERNATIONAL (US) | 1984-11-07 | — | — | EP | disclosed |
| US-4464389-A | SKIN DISORDERS, ANTITUMOR AGENTS | SRI INTERNATIONAL (US) | 1984-08-07 | — | — | US | disclosed |
| US-4454309-A | ADDITION-CONDENSATION POILYMERS OF ALLYL OR ACRYLIC ESTERS; CONTACT LENSES; MEDICAL EQUIPMENT | TYNDALE PLAINS-HUNTER, LTD. (US) | 1984-06-12 | — | — | US | disclosed |
| WO-1984001573-A1 | ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF | STANFORD RES INST INT (US) | 1984-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291502-A1 | HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL | ELOVL6, ELOVL1, ELOVL5 | ALDH1A1 683/4885SMN1; SMN2 2694/4885MAPK1 2430/4885 |
| US-20160311751-A1 | HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL | ELOVL6, ELOVL1, ELOVL3 | ALDH1A1 537/4885SMN1; SMN2 2998/4885MAPK1 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.